≡ Risteys
FG R12 + FR

Documentation Changelog GitHub Contact & Feedback
info icon

This is a non-core endpoint: only basic statistics are computed.

See these related core endpoints for full statistics:

Operations for atrial fibrillation

Endpoint Browser

AF_OPER

Endpoint definition

↥

Endpoint definition steps

FinnGen

Phenotype data

520210

1. Apply sex-specific rule

None

520210

2. Check conditions

None

520210

3. Check pre-conditions, main-only, mode, registry filters

None

0 out of 7 registries used, show all original rules.

0

4. Check minimum number of events

None

0

5. Include endpoints

499

6. Filter based on genotype QC (FinnGen only)

499

Control definitions (FinnGen only)

Controls for this endpoint are individuals that are not cases.

Extra metadata

First used in FinnGen datafreeze
DF4

Case counts by codes

↥

FinnGen case counts by registry codes:

generic upset plot

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

-FinnGen-

Key figures

All Female Male
Number of individuals 499 132 367
Unadjusted period prevalence (%) 0.13 0.04 0.16
Median age at first event (years) 64.76 66.68 64.07

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

Not a core endpoint, no data to show.

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

Matched cohort

Matched cases
456
Matched controls
4561
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
FXA00
NOMESCO Finland
Total cardiopulmonary bypass in normothermia or moderate hypothermia at concurrent surgical procedure
75.5
253.7
287
100
I48
ICD-10 Finland
Atrial fibrillation and flutter
82.2
247.7
433
849
B01AA03
ATC
warfarin; systemic
56.6
244.6
417
724
FM1BE
NOMESCO Finland
Cardiac ultrasound examination through oesophagus
45.0
233.7
308
201
FPD10
NOMESCO Finland
Surgical ablation of atrial fibrillation
+∞
185.4
165
*
I34.1
ICD-10 Finland
Mitral (valve) prolapse
60.0
183.4
214
66
FPD96
NOMESCO Finland
Other operation for atrial fibrillation
+∞
176.9
158
*
TFP20
NOMESCO Finland
Cardiodefibrillation
25.8
174.0
269
240
WX872
NOMESCO Finland
Intensive care
33.6
173.5
238
143
FKB10
NOMESCO Finland
Annuloplasty of mitral valve for insufficiency using ring
267.3
162.8
158
9
FPD00
NOMESCO Finland
Maze procedure for atrial fibrillation
+∞
155.3
140
*
FN1AC
NOMESCO Finland
Angiography of heart and/or coronary arteries
16.2
149.3
361
865
FM1AE
NOMESCO Finland
Standard cardiac ultrasound examination
15.7
148.9
322
604
TFB00
NOMESCO Finland
Cathetrisation of pulmonal artery
63.1
127.8
147
34
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
12.4
122.8
280
517
C07AB07
ATC
bisoprolol; oral
22.6
122.1
427
1798
207
Kela drug reimbursment
Chronic arrhythmias
11.8
117.5
273
511
TFC00
NOMESCO Finland
Catheterisation of right atrium or ventricle
61.3
114.1
132
30
FFM10
NOMESCO Finland
Occlusion or excision of atrial appendage externally with a closing device
1290.3
108.0
101
*
C01BD01
ATC
amiodarone; systemic
25.5
103.1
149
85
AH3
HP
Treatment of arrhythmias, eg atrial fibrillation, in conjunction with other cardiac surgery
+∞
96.3
89
*
FKC50
NOMESCO Finland
Repair of mitral valve for insufficiency using prosthetic chord
186.1
88.7
90
6
I34.00
ICD-10 Finland
Mitral (valve) incompetence NOS or of specified cause, except rheumatic
27.8
79.9
111
52
AC4
HP
MVP
140.2
77.8
81
7
GD1AA
NOMESCO Finland
Thorax X-ray examination
7.6
77.7
372
1671
I34.09
ICD-10 Finland
Mitral (valve) insufficiency
16.9
72.2
120
94
Z95.2
ICD-10 Finland
Presence of prosthetic heart valve
24.3
71.2
103
54
C01AA05
ATC
digoxin; systemic
10.6
69.2
147
195
FKC60
NOMESCO Finland
Resection and reconstruction of leaflet of mitral valve for insufficiency
388.6
67.4
66
*
290
Kela drug reimbursment
Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation
6.7
67.0
213
526
I34.01
ICD-10 Finland
Mitral (valve) regurgitation NOS or of specified cause, except rheumatic
94.8
66.2
72
9
XF404
NOMESCO Finland
Ambulatory ECG
8.3
66.0
168
300
C03CA01
ATC
furosemide; systemic
5.7
65.6
278
974
ZXE30
NOMESCO Finland
More than five and less than seven hours
11.9
63.6
125
140
WX408
NOMESCO Finland
General anesthesy, balanced
5.5
61.7
262
899
R4110
NOMESCO Finland
Physiotherapy
5.4
59.7
257
885
FFM30
NOMESCO Finland
Occlusion of atrial appendage internally by internal suture ligation
+∞
56.4
53
*
ZXE20
NOMESCO Finland
More than three and less than five hours
6.2
56.4
182
438
I48.0
ICD-10 Finland
Paroxysmal atrial fibrillation
9.5
55.3
123
170
351
Kela drug reimbursment
Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation
6.0
54.9
183
456
AH2
HP
Treatment of atrial fibrillation by maze surgery or its modification as the only procedure
+∞
51.0
48
*
K78
ICPC
Atrial fibrillation/flutter
7.1
50.5
139
265
I35.1
ICD-10 Finland
Aortic (valve) insufficiency
10.1
49.9
106
133
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
8.5
49.2
117
178
FM1EE
NOMESCO Finland
Extensive structural and functional ultrasound examination of heart
4.6
47.0
218
755
FGC10
NOMESCO Finland
Annuloplasty of tricuspid valve using prosthetic ring
133.7
45.7
48
*
FM1DE
NOMESCO Finland
Doppler ultrasound examination of heart
6.2
44.9
137
294
FMD10
NOMESCO Finland
Replacement of aortic valve using biological prosthesis
24.5
43.6
62
29
WX404
NOMESCO Finland
Intravenous generell anesthesy
4.7
42.3
176
534
I36.1
ICD-10 Finland
Nonrheumatic tricuspid (valve) insufficiency
30.2
41.9
56
21
AN1
HP
Coronary angiography
4.9
41.8
164
467
XF400
NOMESCO Finland
ECG with 12 standard connections
4.7
41.2
171
515
I50.9
ICD-10 Finland
Heart failure, unspecified
5.1
41.1
153
410
C01BC04
ATC
flecainide; systemic
10.7
40.3
81
90
Z2221
NOMESCO Finland
Medical doctor
3.9
37.7
215
854
ZXD10
NOMESCO Finland
Scheduled procedure
3.6
37.4
267
1274
C07AA07
ATC
sotalol; systemic
9.1
34.6
76
98
K83
ICPC
Heart valve disease NOS
24.8
33.4
47
21
B01AB05
ATC
enoxaparin; parenteral
3.4
31.9
225
1021
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
4.1
31.8
151
496
WZC30
NOMESCO Finland
Teaching
4.3
31.0
134
402
I35.0
ICD-10 Finland
Aortic (valve) stenosis
6.2
30.5
88
169
FKD10
NOMESCO Finland
Replacement of mitral valve using biological prosthesis
40.1
29.8
37
10
I34.9
ICD-10 Finland
Nonrheumatic mitral valve disorder, unspecified
31.7
29.0
38
13
TPH04
NOMESCO Finland
Cathetrisation of vein
3.5
28.9
174
688
PA6DE
NOMESCO Finland
Neck artery ultrasound examination with Doppler method
6.6
28.1
76
133
AA1
HP
Conventional CABG
10.3
27.3
55
60
AP3
HP
Catheterization of the right and left side of the heart
42.9
26.2
32
8
XFP20
NOMESCO Finland
Check up of cardiac pacemaker
5.0
26.0
91
217
Z3226
NOMESCO Finland
Physiotherapist
3.5
26.0
146
538
C03DA01
ATC
spironolactone; oral
4.2
25.7
109
316
I34.0
ICD-10 Finland
Mitral (valve) insufficiency
17.6
25.0
39
24
PD5BD
NOMESCO Finland
Extensive CT of aorta
10.6
24.9
49
51
FNA01
NOMESCO Finland
Anastomosis to coronary artery from internal mammary artery, one distal anastamosis
5.6
24.9
77
159
B01AF02
ATC
apixaban; oral
4.2
24.7
106
309
ZXD05
NOMESCO Finland
Urgent procedure
2.9
24.2
204
991
ZXE02
NOMESCO Finland
Procedure duration 10 to 19 minutes
7.0
24.2
62
100
ZXE00
NOMESCO Finland
One hour or less
2.8
24.1
239
1286
FKC20
NOMESCO Finland
Plastic repair of mitral valve leaflet for insufficiency
57.2
23.3
27
5
XF402
NOMESCO Finland
ECG with work load test
3.9
22.9
107
335
201
Kela drug reimbursment
Chronic cardiac insufficiency
6.4
22.2
61
108
AP1
HP
Catheterization of the left side of the heart
12.4
22.2
40
35
WX892
NOMESCO Finland
Monitored bed care
4.4
22.1
87
232
K84
ICPC
Heart disease other
8.4
22.0
49
64
Z95.0
ICD-10 Finland
Presence of electronic cardiac devices
5.3
21.7
70
151
Z95.8
ICD-10 Finland
Presence of other cardiac and vascular implants and grafts
33.0
21.7
28
9
TFP00
NOMESCO Finland
Temporary use of transvenous or epicardial pacemaker
16.8
20.9
33
21
I48.9
ICD-10 Finland
Atrial fibrillation and atrial flutter, unspecified
5.1
20.7
68
150
I50.0
ICD-10 Finland
Congestive heart failure
4.5
20.6
78
200
Z95.1
ICD-10 Finland
Presence of aortocoronary bypass graft
5.4
20.0
63
132
C09AA05
ATC
ramipril; oral
2.7
19.9
185
924
FFC00
NOMESCO Finland
Suture of ostium secundum type ASD
109.8
19.7
21
*
AD1
HP
TVP
109.8
19.7
21
*
I47.1
ICD-10 Finland
Supraventricular tachycardia
6.6
19.4
51
85
FKC96
NOMESCO Finland
Other repair of mitral valve for insufficiency
48.2
19.4
23
5
FWD00
NOMESCO Finland
Reoperation for superficial haemorrhage in surgery of heart and major thoracic vessels
21.2
19.3
28
14
WX402
NOMESCO Finland
General anaesthesia
3.1
18.6
120
471
N02BE01
ATC
paracetamol; systemic, rectal
3.9
18.6
420
3422
TFP35
NOMESCO Finland
Electroanatomical mapping
12.2
18.3
33
29
TFP34
NOMESCO Finland
Electrophysiological investigation
6.9
18.2
46
73
FNC10
NOMESCO Finland
Aorto-coronary venous bypass with single distal anastomosis
10.4
18.0
35
36
AB2
HP
AVR bio, stent
21.1
17.9
26
13
Z45.0
ICD-10 Finland
Adjustment and management of cardiac devices
5.2
17.9
57
121
I71.2
ICD-10 Finland
Thoracic aortic aneurysm, without mention of rupture
6.3
17.8
48
83
342
Kela drug reimbursment
Dronedarone
17.8
17.6
27
16
Z95.3
ICD-10 Finland
Presence of xenogenic heart valve
30.2
17.6
23
8
ZXE03
NOMESCO Finland
Procedure duration 20 to 29 minutes
4.9
17.5
60
138
B01AF01
ATC
rivaroxaban; oral
3.3
17.5
100
361
ZXE40
NOMESCO Finland
More than seven and less than nine hours
7.4
17.4
42
62
Z95.4
ICD-10 Finland
Presence of other heart-valve replacement
32.9
17.2
22
7
GA4YT
NOMESCO Finland
Puncture of pleura with ultrasound guidance
7.6
17.0
40
57
AP2
HP
Catheterization of the right side of the heart
36.6
16.8
21
6
K80
ICPC
Cardiac arrhythmia NOS
4.1
16.6
68
187
I25.1
ICD-10 Finland
Atherosclerotic heart disease
2.5
16.5
166
848
Z03.5
ICD-10 Finland
Observation for other suspected cardiovascular diseases
4.3
16.5
64
167
TFP46
NOMESCO Finland
Ablation treatment of atrial fibrillation
9.7
15.9
32
35
Z3231
NOMESCO Finland
Registered nurse
2.4
15.8
174
927
C01BD07
ATC
dronedarone; oral
18.0
15.8
24
14
I20.81
ICD-10 Finland
Other angina pectoris stenosed coronary artery
3.3
15.6
85
294
J01CA04
ATC
amoxicillin; systemic
2.6
15.3
372
2887
I49.5
ICD-10 Finland
Sick sinus syndrome
5.1
15.1
49
106
FKC00
NOMESCO Finland
Repair of mitral valve for insufficiency using ring
58.7
14.9
17
*
XF620
NOMESCO Finland
Examination of circulation with color method
21.9
14.8
21
10
FL1AC
NOMESCO Finland
Left cardioangiography
9.9
14.7
29
31
B01AE07
ATC
dabigatran etexilate; oral
4.8
14.5
49
111
FKD00
NOMESCO Finland
Replacement of mitral valve using mechanical prosthesis
44.0
14.2
17
*
ZXE50
NOMESCO Finland
More than nine and less than 12 hours
9.9
14.2
28
30
TPH07
NOMESCO Finland
Cathetrisation of artery
3.2
14.1
82
295
I48.1
ICD-10 Finland
Persistent atrial fibrillation
6.6
14.1
36
58
I35.2
ICD-10 Finland
Aortic (valve) stenosis with insufficiency
6.2
14.1
38
66
XF640
NOMESCO Finland
NA
6.3
13.9
37
63
T81.0
ICD-10 Finland
Haemorrhage and haematoma complicating a procedure, not elsewhere classified
4.1
13.8
55
147
I48.2
ICD-10 Finland
Chronic atrial fibrillation
6.4
13.8
36
60
C03EB01
ATC
furosemide and potassium-sparing agents; systemic
6.2
13.8
37
64
ZXE04
NOMESCO Finland
Procedure duration 30 to 39 minutes
4.1
13.7
54
143
AF1
HP
Surgery of congenital heart defect
+∞
13.6
13
*
I97.0
ICD-10 Finland
Postcardiotomy syndrome
35.2
13.6
17
5
AC2
HP
MVR bio
35.2
13.6
17
5
GAB10
NOMESCO Finland
Antero- or postero-lateral thoracotomy
23.3
13.0
18
8
FNC20
NOMESCO Finland
Aorto-coronary venous bypass with two distal anastomoses
6.1
12.7
34
59
413
HP
Radioablation / Microwave Maze also as an adjunct to other procedures
+∞
12.6
12
*
FKC10
NOMESCO Finland
Suture of cleft mitral leaflet
+∞
12.6
12
*
TFP30
NOMESCO Finland
Cathetric examination for cardiac arrythmia
11.5
12.2
22
20
FM1DG
NOMESCO Finland
Very extensive MRI examination of heart with high intesity magnet
12.2
11.9
21
18
FMD00
NOMESCO Finland
Replacement of aortic valve using mechanical prosthesis
13.0
11.7
20
16
WX870
NOMESCO Finland
Other postsurgical intensive care
19.5
11.7
17
9
C01BA03
ATC
disopyramide; systemic
19.5
11.7
17
9
TFC25
NOMESCO Finland
Transseptal catheterisation of left atrium or ventricle
10.4
11.6
22
22
FN1BC
NOMESCO Finland
Extensive angiography of hear and/or coronary arteries
3.6
11.6
53
160
I34
ICD-10 Finland
Nonrheumatic mitral valve disorders
+∞
11.5
11
*
Q21.19
ICD-10 Finland
Atrial septal defect NOS
122.9
11.5
12
*
ZXE10
NOMESCO Finland
More than one and less than three hours
2.0
11.3
197
1242
AR6
HP
Catheter ablation of arrhythmia, target: atrial fibrillation
20.7
11.2
16
8
GD1BD
NOMESCO Finland
Thorax extensive CT-examination
3.6
11.2
51
154
I49.3
ICD-10 Finland
Ventricular premature depolarization
3.5
10.9
51
157
C08DA01
ATC
verapamil; systemic
4.3
10.7
39
96
Q21.09
ICD-10 Finland
Ventricular septal defect NOS
61.4
10.7
12
*
AJX
HP
Other surgery on the heart or aorta
112.5
10.5
11
*
I47.2
ICD-10 Finland
Ventricular tachycardia
5.5
10.3
30
58
FCA60
NOMESCO Finland
Resection of aortic root and ascending aorta with reimplantation of coronary arteries and use of composite graft with mechanical valve prosthesis
24.0
10.3
14
6
3A064
NOMESCO Finland
NA
24.0
10.3
14
6
Q21.10
ICD-10 Finland
Persistent ostium secundum
24.0
10.3
14
6
AQ1
HP
Conventional electrophysiological examination
8.2
10.2
22
28
N02AX02
ATC
tramadol; systemic, rectal
1.9
10.1
227
1557
M01AE01
ATC
ibuprofen; systemic, rectal
0.5
10.1
285
3501
A02BC02
ATC
pantoprazole; systemic
1.9
10.1
315
2434
I49.9
ICD-10 Finland
Cardiac arrhythmia, unspecified
2.7
10.0
72
297
C07AB02
ATC
metoprolol; systemic
2.1
9.9
127
699
FPE30
NOMESCO Finland
Replacement of transvenous cardiac pacemaker pulse generator
8.7
9.7
20
24
WW502
NOMESCO Finland
Autotransfusion
11.7
9.6
17
15
EB1HA
NOMESCO Finland
Panorama tomography of teeth and jaws or similar X-ray examination
1.9
9.6
197
1303
I44.2
ICD-10 Finland
Atrioventricular block, complete
4.9
9.5
30
64
71
HP
Electrophysiological Special Examination
18.0
9.5
14
8
742
NOMESCO Finland
NA
30.7
9.4
12
*
FM1CD
NOMESCO Finland
Very extensive CT of heart
22.2
9.4
13
6
H03BB01
ATC
carbimazole; oral
4.9
9.4
30
65
E05.9
ICD-10 Finland
Thyrotoxicosis, unspecified
6.5
9.2
23
37
Q23.11
ICD-10 Finland
Bicuspid aortic valve
11.8
9.1
16
14
ZSF00
NOMESCO Finland
Procedure related to previous procedure classified in chapter F
19.1
9.0
13
7
K99
ICPC
Cardiovascular disease other
4.4
8.9
31
74
C07AB03
ATC
atenolol; systemic
3.3
8.8
43
138
FPE20
NOMESCO Finland
Implantation of transvenous cardiac pacemaker with atrial and ventricular electrodes
3.3
8.7
44
144
WX002
NOMESCO Finland
Sedation and analgesia
2.1
8.6
111
606
FCA70
NOMESCO Finland
Resection of aortic root and ascending aorta with reimplantation of coronary arteries and use of biological valve prosthesis and tube graft
16.7
8.6
13
8
GAA31
NOMESCO Finland
Thoracoscopy
28.1
8.5
11
*
I34.8
ICD-10 Finland
Other nonrheumatic mitral valve disorders
20.5
8.5
12
6
I50.1
ICD-10 Finland
Left ventricular failure
3.5
8.4
39
120
GD1LA
NOMESCO Finland
GD
6.0
8.4
22
38
WX902
NOMESCO Finland
External defibrillation of heart
11.0
8.3
15
14
TFP32
NOMESCO Finland
Cathetric treatmen of cardiac arrythmia
11.0
8.3
15
14
FC1AC
NOMESCO Finland
Angiography of thoracal aortta
10.3
8.1
15
15
FPW96
NOMESCO Finland
Other operation for arhythmia or disturbance of impulse propagation
13.3
7.9
13
10
FPE00
NOMESCO Finland
Implantation of transvenous cardiac pacemaker with ventricular electrode
5.0
7.9
24
50
4273A
ICD-9 Finland
Cardiac dysrhythmias, Atrial fibrillation and flutter
5.7
7.8
21
38
B01AF03
ATC
edoxaban; oral
7.6
7.7
17
23
ZXE90
NOMESCO Finland
More than 22 hours
10.3
7.6
14
14
R06.0
ICD-10 Finland
Dyspnoea
1.9
7.4
129
787
Q21.30
ICD-10 Finland
Tetralogy of Fallot
+∞
7.3
7
*
474
NOMESCO Finland
NA
+∞
7.3
7
*
3A422
NOMESCO Finland
NA
+∞
7.3
7
*
FFM20
NOMESCO Finland
Amputation of atrial appendage
+∞
7.3
7
*
I49.8
ICD-10 Finland
Other specified cardiac arrhythmias
4.8
7.3
23
50
FPH10
NOMESCO Finland
Open removal of transvenous cardiac pacemaker or cardioverter-defibrillator
30.5
7.2
9
*
I48.4
ICD-10 Finland
Atypical atrial flutter
20.4
7.2
10
5
81
HP
Angiography of the heart and coronary arteries
2.7
7.1
48
189
XF600
NOMESCO Finland
Bloodpressure measurement
2.8
7.0
42
157
WZA00
NOMESCO Finland
Short statement of of health and health related matters
3.1
6.9
36
122
R04.0
ICD-10 Finland
Epistaxis
2.6
6.9
48
195
R00.0
ICD-10 Finland
Tachycardia, unspecified
3.9
6.9
27
73
I34.2
ICD-10 Finland
Nonrheumatic mitral (valve) stenosis
11.2
6.8
12
11
I33.0
ICD-10 Finland
Acute and subacute infective endocarditis
11.2
6.8
12
11
GA1AE
NOMESCO Finland
Ultrasound examination of thorax
4.8
6.8
21
45
TFC20
NOMESCO Finland
Catheterisation of both sides of heart
40.7
6.8
8
*
72
HP
Catheter ablation of arrhythmia
17.0
6.8
10
6
I25.0
ICD-10 Finland
Atherosclerotic cardiovascular disease, so described
2.7
6.7
43
167
TFP44
NOMESCO Finland
Ablation treatment of typical atrial flutter
6.0
6.7
17
29
ZXE05
NOMESCO Finland
Procedure duration 40 to 49 minutes
3.1
6.6
34
114
PA6AE
NOMESCO Finland
Ulrasound examination of neck vasculature
10.2
6.6
12
12
ZX120
NOMESCO Finland
Intravenous
2.4
6.5
57
261
A12BA01
ATC
potassium chloride; oral
3.3
6.4
30
94
WZB00
NOMESCO Finland
Telephone receipt or other advice
1.8
6.4
124
780
ZXE01
NOMESCO Finland
Procedure duration 0 to 9 minutes
6.7
6.4
15
23
I37.1
ICD-10 Finland
Pulmonary valve insufficiency
+∞
6.3
6
*
FJF10
NOMESCO Finland
Replacement of pulmonary valve using biological prosthesis
+∞
6.3
6
*
FKC40
NOMESCO Finland
Suture of chord or papillary muscle of mitral valve
+∞
6.3
6
*
FFM00
NOMESCO Finland
Occlusion or excision of atrial appendage by ligation
+∞
6.3
6
*
TFC99
NOMESCO Finland
Catheterisation of heart with other procedure
+∞
6.3
6
*
120
NOMESCO Finland
NA
+∞
6.3
6
*
FGD00
NOMESCO Finland
Repair of tricuspid valve using suture
+∞
6.3
6
*
3A149
NOMESCO Finland
NA
+∞
6.3
6
*
FPB22
NOMESCO Finland
Transvenous radiofrequency ablation of aberrant pathway or focus of heart
27.1
6.2
8
*
FN1CC
NOMESCO Finland
Very extensive angiography of heart and/or coronary arteries
4.5
6.1
20
46
I35.9
ICD-10 Finland
Aortic valve disorder, unspecified
12.7
6.1
10
8

LabWAS

↥
OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
261
462
10.75
160.31
2.8
2.5
ug/l
27.3
7.6
15.08
256
408
(3022217) INR in Platelet poor plasma by Coagulation assay
303
656
10.21
155.44
46.5
25.4
inr
2.2
1.3
5.15
15
89
(3018677) aPTT in Platelet poor plasma by Coagulation assay
295
768
7.95
121.48
2.8
2.2
s
32.7
29.7
12.12
290
744
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
194
394
7.42
99.58
3.1
2.8
ng/l
288.4
205.5
1.79
183
356
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
376
1487
7.20
92.13
4.7
3.1
ng/l
1603.6
1437.1
0.31
367
1292
(3032080) INR in Blood by Coagulation assay
432
1988
9.74
88.26
28.5
10.0
inr
2.1
1.3
16.44
81
553
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
302
1094
5.46
78.31
2.5
2.6
—
—
—
0
0
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
266
880
5.33
76.78
5.3
3.9
ng/l
3074.3
389.9
6.71
254
741
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
114
186
7.65
70.23
3.9
2.5
u/ml
0.3
0.4
1.38
76
93
(3044640) Blood type and Crossmatch panel - Blood
320
1434
4.43
57.70
2.9
2.6
—
—
—
0
0
(3012095) Magnesium [Moles/volume] in Serum or Plasma
211
769
4.02
49.38
4.4
3.8
mmol/l
0.8
0.8
3.39
197
724
(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
175
570
4.19
47.79
3.1
4.4
u/l
273.0
247.6
0.94
167
539
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
298
1397
3.81
47.39
2.6
2.3
u/l
444.6
287.6
1.38
289
1317
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
372
2022
4.30
47.34
4.1
4.2
—
—
—
0
0
(3014576) Chloride [Moles/volume] in Serum or Plasma
187
659
3.94
45.35
8.9
7.6
mmol/l
105.9
104.3
4.80
187
642
(3020779) Urea [Moles/volume] in Serum or Plasma
145
444
4.19
42.58
6.7
8.2
mmol/l
9.2
10.2
0.75
140
425
(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method
75
131
6.56
42.46
3.1
2.1
%
80.6
85.7
1.02
75
125
(3036489) Thrombin time
82
159
5.97
41.73
2.6
2.0
s
23.3
22.1
0.64
82
148
(3000991) Gas panel - Venous blood
138
423
4.13
40.26
11.2
9.7
—
—
—
0
0
(3024928) Oxygen saturation in Venous blood
65
104
7.04
39.96
4.3
3.1
—
—
—
0
0
(3013826) Glucose [Moles/volume] in Serum or Plasma
424
2686
4.85
39.85
8.8
5.4
mmol/l
6.6
6.8
1.76
408
2543
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
283
1390
3.39
39.64
3.0
3.7
u/l
35.2
35.0
0.03
277
1326
(3007628) Bicarbonate [Moles/volume] standard in Venous blood
90
225
4.66
33.97
4.5
4.3
mmol/l
24.4
24.2
0.25
85
205
(3027456) Digoxin [Moles/volume] in Serum or Plasma
57
98
6.44
32.55
2.9
3.0
nmol/l
0.7
0.9
0.80
48
79
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
380
2389
3.48
32.44
6.5
7.1
umol/l
17.4
12.3
5.25
367
2276
(3027945) Reticulocytes/100 erythrocytes in Blood
154
586
3.35
31.69
2.4
2.7
%
1.6
1.8
1.47
147
535
(3027946) Carbon dioxide [Partial pressure] in Arterial blood
152
594
3.24
29.70
12.9
8.2
kpa
5.1
5.1
0.10
144
574
(3027801) Oxygen [Partial pressure] in Arterial blood
152
594
3.24
29.70
12.9
8.2
kpa
13.7
11.9
1.82
145
576
(3016502) Oxygen saturation in Arterial blood
143
547
3.26
28.87
13.2
8.6
%
95.0
95.5
0.23
135
529
(3003396) Base excess in Arterial blood by calculation
150
596
3.17
28.35
13.0
8.2
mmol/l
0.9
1.1
0.21
124
468
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
91
288
3.64
24.51
17.8
11.0
—
—
—
0
0
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
81
242
3.80
23.71
2.2
1.7
g/l
1.2
1.6
1.77
66
209
(3004789) Transferrin [Mass/volume] in Serum or Plasma
157
701
2.81
23.48
2.9
2.6
g/l
2.3
2.3
1.00
148
653
(3022948) Iron [Moles/volume] in Serum or Plasma
165
757
2.76
23.40
2.9
2.6
umol/l
12.2
12.8
0.39
157
705
(3004119) Hemoglobin [Mass/volume] in Venous blood
93
312
3.43
22.82
5.1
3.4
g/l
123.8
128.3
0.98
86
307
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
150
669
2.78
22.33
3.0
2.6
%
20.7
22.8
0.99
129
576
(3002032) Base excess in Venous blood by calculation
116
450
3.06
22.33
4.2
4.0
mmol/l
1.7
2.0
0.44
100
355
(3021447) Carbon dioxide [Partial pressure] in Venous blood
116
451
3.05
22.23
4.3
4.0
kpa
5.8
5.8
0.09
110
440
(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood
20
14
14.84
22.03
11.2
7.8
—
—
—
0
0
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
318
2051
2.52
21.44
10.1
6.7
mmol/l
1.2
1.2
7.93
300
1869
(40758558) Short blood count panel - Blood
197
1060
2.42
19.40
7.2
7.1
—
—
—
0
0
(3024354) Oxygen [Partial pressure] in Venous blood
98
375
3.01
19.12
3.8
3.1
kpa
4.5
4.5
0.06
93
364
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
435
3376
3.25
18.54
8.8
8.4
u/l
78.5
80.2
0.35
421
3175
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
201
1109
2.36
18.52
2.7
2.1
mg/l
2.9
3.1
0.88
176
944
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
327
2226
2.36
18.20
10.6
7.7
mmol/l
1.2
1.2
10.55
293
1905
(3044889) 12 lead EKG panel
408
3119
2.69
16.76
9.1
4.2
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
37
79
4.98
16.62
1.4
1.5
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
37
79
4.98
16.62
1.4
1.5
—
—
—
0
0
(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood
70
239
3.24
16.48
3.4
2.7
%
1.2
1.2
0.01
70
239
(3023368) Bacteria identified in Blood by Culture
223
1364
2.15
15.27
5.8
4.8
—
—
—
0
0
(3003458) Phosphate [Moles/volume] in Serum or Plasma
129
633
2.40
15.06
6.1
6.5
mmol/l
1.0
1.0
1.35
120
585
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
271
1807
2.09
14.55
6.0
4.0
ng/l
79.0
42.9
1.06
217
1394
(3001122) Ferritin [Mass/volume] in Serum or Plasma
248
1633
2.03
13.42
3.4
2.7
ug/l
157.2
177.3
0.61
228
1492
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
110
539
2.34
12.68
2.2
3.2
umol/l
12.3
9.6
0.41
98
483
(3011648) Oxygen content in Venous blood
22
38
6.01
12.37
1.9
1.7
%
11.4
10.5
0.37
22
38
(3019060) Gas panel - Arterial blood
78
334
2.58
12.02
9.4
4.8
—
—
—
0
0
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
159
921
2.07
11.98
2.4
1.7
mg/l
1.9
1.3
1.06
123
724
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
80
351
2.52
11.71
3.5
3.1
ml/min/173m2
65.9
63.2
0.19
35
145
(3052851) Hemolysis interference index of Serum or Plasma
43
135
3.39
11.52
6.0
3.6
—
—
—
0
0
(3038071) Oxygen [Partial pressure] in Mixed venous blood
13
13
10.24
11.38
6.1
7.8
—
—
—
0
0
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
108
548
2.24
11.37
1.9
1.9
—
—
—
0
0
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
474
4149
3.84
11.15
28.0
16.6
mg/l
37.0
26.8
8.02
443
3378
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
438
3680
2.56
11.13
5.7
4.3
mu/l
2.1
2.0
0.91
398
3307
(42870588) Differential panel, method unspecified - Blood
221
1465
1.91
11.11
6.3
5.9
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
106
546
2.20
10.71
1.8
1.9
—
—
—
0
0
(3001604) Monocytes [#/volume] in Blood
290
2118
1.88
10.62
6.5
5.9
e9/l
0.7
0.6
1.61
241
1836
(3006315) Basophils [#/volume] in Blood
290
2126
1.87
10.41
6.5
5.9
e9/l
0.0
0.0
0.93
241
1853
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
142
828
2.00
10.28
3.0
2.9
e6/l
0.6
1.0
1.42
78
506
(3024561) Albumin [Mass/volume] in Serum or Plasma
271
1955
1.85
10.14
4.9
5.4
g/l
34.7
35.0
0.43
254
1830
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
135
778
2.01
10.08
3.2
3.2
e6/l
1.6
1.3
0.16
71
462
(3019198) Lymphocytes [#/volume] in Blood
292
2162
1.85
9.98
6.6
6.0
e9/l
1.8
1.9
0.13
248
1911
(36304419) Bacteria [Presence] in Urine
191
1242
1.87
9.92
3.6
3.3
—
—
—
0
0
(3030467) Casts [#/volume] in Urine by Automated count
199
1311
1.86
9.92
3.7
3.3
e6/l
0.4
0.5
0.23
146
1005
(3013650) Neutrophils [#/volume] in Blood by Automated count
323
2473
1.87
9.86
8.4
9.7
e9/l
4.3
4.2
0.51
267
2176
(3018418) pH of Serum or Plasma
200
1322
1.86
9.84
4.0
4.6
ph
7.4
7.4
0.94
21
256
(3013115) Eosinophils [#/volume] in Blood
293
2192
1.82
9.47
7.1
6.1
e9/l
0.2
0.2
0.17
251
1941
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
133
779
1.96
9.40
1.9
2.0
—
—
—
0
0
(3042936) Bacteria identified in Isolate by Culture
125
725
1.97
9.05
2.3
2.1
—
—
—
0
0
(3043409) Potassium [Moles/volume] in Arterial blood
42
153
2.91
8.78
5.4
3.6
mmol/l
4.2
4.0
1.61
42
140
(3018010) Neutrophils/100 leukocytes in Blood
271
2011
1.76
8.72
6.6
6.0
%
59.9
58.0
1.59
253
1893
(3003694) ABO and Rh group [Type] in Blood
172
1120
1.82
8.65
1.3
1.3
—
—
—
0
0
(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay
14
22
6.52
8.57
2.1
2.3
%
79.6
106.9
2.26
14
22
(3022096) Basophils/100 leukocytes in Blood
264
1951
1.75
8.56
6.7
6.1
%
0.7
0.6
0.18
247
1834
(3006504) Eosinophils/100 leukocytes in Blood
268
1999
1.74
8.32
6.7
6.1
%
2.9
3.0
0.03
251
1874
(3019069) Monocytes/100 leukocytes in Blood
269
2012
1.73
8.24
6.9
6.4
%
9.5
9.0
1.76
252
1897
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
359
2917
1.82
8.20
4.5
3.5
pmol/l
15.5
15.0
3.06
327
2600
(3034037) Hematocrit [Volume Fraction] of Mixed venous blood
10
11
9.26
8.11
7.4
8.5
—
—
—
0
0
(3002030) Lymphocytes/100 leukocytes in Blood
272
2048
1.72
8.07
6.8
6.3
%
24.4
26.4
2.06
254
1913
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
67
322
2.25
7.91
1.5
1.7
—
—
—
0
0
(3021589) Normoblasts [#/volume] in Blood
251
1862
1.70
7.76
11.0
10.7
e9/l
0.0
0.0
0.10
193
1538
(3020891) Body temperature
47
194
2.57
7.76
5.3
4.5
—
—
—
0
0
(3023520) Reticulocytes [#/volume] in Blood
83
444
2.04
7.45
2.8
2.7
e9/l
68.6
69.2
0.04
51
348
(3007853) Bacteria identified in Skin by Aerobe culture
97
552
1.94
7.30
2.0
1.7
—
—
—
0
0
(3000492) Spirometry study
76
400
2.06
7.12
1.7
1.5
—
—
—
0
0
(3002582) Erythrocytes [#/volume] in Urine
202
1439
1.68
7.09
3.8
3.4
e6/l
108.8
111.9
0.01
146
1132
(1761868) Lipid panel - Serum or Plasma
88
1436
0.53
6.81
2.8
3.1
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
421
3673
1.94
6.73
38.2
17.6
%
38.1
40.1
5.22
328
2475
(3013707) Erythrocyte sedimentation rate by Westergren method
370
3109
1.74
6.67
4.1
4.1
mm/h
14.6
13.0
1.00
342
2861
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
31
112
2.88
6.60
1.1
1.3
—
—
—
0
0
(3018095) Leukocytes [#/volume] in Urine
218
1613
1.62
6.43
4.5
3.9
e6/l
60.1
83.3
0.36
153
1202
(3011397) Hemoglobin [Presence] in Urine by Test strip
141
933
1.71
6.41
3.1
3.7
—
—
—
0
0
(3018405) Lactate [Moles/volume] in Arterial blood
44
193
2.40
6.40
5.1
3.7
mmol/l
1.1
1.5
2.85
44
187
(3024891) Influenza virus A+B Ag [Presence] in Specimen
27
97
2.89
5.82
1.1
1.2
—
—
—
0
0
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
478
4428
2.89
5.80
14.8
11.7
u/l
26.7
27.8
0.88
469
4275
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
445
4006
2.02
5.76
4.9
4.3
mmol/l
1.2
1.3
2.05
416
3644
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
224
1704
1.57
5.68
3.9
3.4
—
—
—
0
0
(3026493) Urate [Moles/volume] in Serum or Plasma
175
1260
1.60
5.60
3.0
3.0
umol/l
2261.5
7123.5
1.33
152
1080
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
73
417
1.88
5.38
3.0
2.5
u/l
38.0
34.4
0.35
65
357
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
53
271
2.07
5.36
1.5
1.5
—
—
—
0
0
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
39
177
2.31
5.28
1.3
3.2
g/l
3.5
3.2
0.72
30
143
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
461
4235
2.16
5.14
6.1
5.4
mmol/l
2.5
2.6
2.07
439
3869
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
441
3991
1.90
5.12
29.3
15.4
ml/min/173m2
75.7
77.7
1.33
409
3352
(40761511) CBC panel - Blood by Automated count
466
4306
2.24
4.99
28.7
15.7
—
—
—
0
0
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
454
4156
2.02
4.98
5.4
4.8
mmol/l
4.2
4.5
4.14
432
3818
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
40
189
2.21
4.94
1.3
3.0
g/l
4.1
3.7
1.04
31
141
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
40
189
2.21
4.94
1.3
3.0
—
—
—
0
0
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
40
189
2.21
4.94
1.3
3.0
g/l
7.1
7.4
0.20
31
147
(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
13
32
4.14
4.92
1.5
1.5
—
—
—
0
0
(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
13
32
4.14
4.92
1.5
1.5
—
—
—
0
0
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
452
4137
1.98
4.87
5.1
5.0
mmol/l
6.0
6.1
1.20
424
3753
(3000093) Morphology [Interpretation] in Blood Narrative
16
47
3.48
4.78
1.2
1.1
—
—
—
0
0
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
451
4131
1.95
4.75
5.3
4.8
mmol/l
1.3
1.4
2.46
429
3767
(3000850) Epithelial cells [#/volume] in Urine
140
991
1.57
4.69
2.8
2.7
e6/l
4.0
3.7
0.16
115
872
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
234
1854
1.49
4.62
2.1
2.0
pmol/l
96.6
93.2
0.59
114
996
(40760888) Immunoglobulin light chains.free panel - Serum
29
125
2.40
4.43
1.2
4.6
—
—
—
0
0
(3007461) Platelets [#/volume] in Blood
482
4558
2.69
4.19
43.6
24.2
e9/l
214.5
238.3
16.38
475
4442
(3026361) Erythrocytes [#/volume] in Blood
482
4560
2.67
4.15
43.7
24.2
e12/l
4.3
4.5
16.12
474
4430
(3010813) Leukocytes [#/volume] in Blood
482
4560
2.67
4.15
43.8
24.3
e9/l
7.1
6.8
1.58
474
4431
(3021879) Hepatitis B virus core Ab [Presence] in Serum
47
255
1.93
4.06
1.2
1.4
—
—
—
0
0
(3021960) Folate [Moles/volume] in Serum or Plasma
151
1126
1.49
3.88
1.6
1.6
nmol/l
18.1
20.2
1.19
131
940
(3026008) Bacteria identified in Urine by Culture
157
1184
1.48
3.80
3.0
3.3
—
—
—
0
0
(40757373) Influenza virus identified in Isolate
6
5
12.12
3.77
1.2
3.0
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
75
1114
0.62
3.69
3.7
3.4
—
—
—
0
0
(3020630) Protein [Mass/volume] in Serum or Plasma
65
402
1.71
3.68
1.7
3.3
g/l
65.9
66.3
0.14
60
364
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
53
311
1.79
3.60
1.6
1.7
—
—
—
0
0
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
24
105
2.35
3.58
1.5
1.6
—
—
—
0
0
(3018572) Chloride [Moles/volume] in Blood
25
112
2.30
3.54
19.4
7.5
mmol/l
107.4
105.0
2.11
20
104
(3039000) Anion gap in Blood
25
112
2.30
3.54
19.4
7.5
mmol/l
11.8
11.3
0.23
20
104
(3026782) Osmolality of Urine
126
922
1.49
3.52
3.5
3.0
mosm/kgh2o
565.9
581.3
0.34
101
786
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
30
146
2.12
3.49
1.9
1.7
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
75
494
1.61
3.34
1.4
1.6
—
—
—
0
0
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
28
136
2.12
3.29
1.8
1.6
—
—
—
0
0
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
27
130
2.14
3.24
1.5
1.5
—
—
—
0
0
(3037467) Urinalysis macro (dipstick) panel - Urine
329
2894
1.40
3.15
4.1
4.3
—
—
—
0
0
(3001964) Herpes simplex virus Ag [Presence] in Specimen
6
8
7.57
3.06
1.2
2.3
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
23
111
2.12
2.77
1.1
1.2
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
23
112
2.10
2.71
1.1
1.2
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
63
421
1.57
2.66
1.4
1.6
—
—
—
0
0
(3019309) Folate [Moles/volume] in Red Blood Cells
114
862
1.42
2.63
1.8
1.7
nmol/l
999.4
1183.5
1.50
82
659
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
9
25
3.65
2.58
1.2
1.4
—
—
—
0
0
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
110
829
1.42
2.58
3.0
3.4
mmol/l
2.5
2.5
0.13
89
733
(3047181) Lactate [Moles/volume] in Blood
28
150
1.92
2.57
20.0
7.0
mmol/l
1.5
1.2
0.42
22
133
(3017143) Hepatitis C virus Ab [Presence] in Serum
61
409
1.56
2.54
1.4
1.6
—
—
—
0
0
(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence
29
158
1.89
2.54
1.4
1.7
—
163.3
—
0
6
(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay
6
12
5.05
2.41
1.7
2.4
%
172.8
150.1
—
6
12
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
22
111
2.03
2.39
1.1
1.2
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
79
568
1.46
2.38
11.9
7.8
—
—
—
0
0
(3044941) Cell count panel - Synovial fluid
16
71
2.30
2.36
1.1
1.4
—
—
—
0
0
(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex
7
18
3.93
2.26
1.0
1.1
—
—
—
0
0
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
188
1572
1.31
2.25
2.0
2.3
nmol/l
79.4
76.7
0.61
155
1374
(3035320) C reactive protein [Mass/volume] in Body fluid
9
29
3.14
2.23
2.3
1.9
—
—
—
0
0
(3015377) Calcium [Moles/volume] in Serum or Plasma
172
1422
1.32
2.23
3.3
3.7
mmol/l
2.3
2.3
0.06
138
1241
(3004588) Protein electrophoresis panel - Serum or Plasma
50
331
1.57
2.22
1.5
3.0
—
—
—
0
0
(3051651) Icteric interference index of Serum or Plasma
10
36
2.81
2.21
10.0
4.2
—
—
—
0
0
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
426
4003
1.44
2.18
6.0
6.4
mmol/mol
39.5
40.8
3.06
399
3698
(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
20
101
2.02
2.18
6.1
6.8
iu/ml
705.2
257.1
—
5
19
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
25
137
1.87
2.17
1.0
1.4
—
—
—
0
0
(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate
7
19
3.72
2.15
3.0
4.9
—
—
—
0
0
(3037522) Nuclear Ab [Titer] in Serum
72
519
1.45
2.15
1.4
1.3
titre
257.8
441.4
1.24
18
115
(3037756) Immunofixation for Serum or Plasma
22
117
1.92
2.09
1.3
1.7
—
—
—
0
0
(3003327) Ova and parasites identified in Stool by Light microscopy
21
112
1.91
1.99
2.2
1.6
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
247
2167
1.28
1.98
2.2
2.4
—
—
—
0
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
22
121
1.86
1.91
1.5
1.9
—
—
—
0
0
(3046279) Procalcitonin [Mass/volume] in Serum or Plasma
34
213
1.64
1.91
2.6
2.0
ug/l
0.5
2.8
1.02
25
189
(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay
12
53
2.30
1.82
1.6
1.2
u/ml
2.0
9.0
—
5
10
(3005532) Lymphocytes/100 leukocytes in Pleural fluid
7
23
3.07
1.80
1.9
1.3
%
44.4
59.2
—
7
16
(3051593) INR in Capillary blood by Coagulation assay
7
23
3.07
1.80
9.7
6.2
—
—
—
0
0
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
10
41
2.47
1.76
1.0
1.2
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
26
155
1.71
1.76
1.1
1.3
—
—
—
0
0
(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
15
75
2.03
1.71
1.8
2.8
—
788.7
—
0
9
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
14
69
2.06
1.66
1.0
1.1
—
—
—
0
0
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
21
120
1.78
1.65
1.5
1.9
—
—
—
0
0
(3051611) Lipemic interference index of Serum or Plasma
11
49
2.27
1.64
10.5
4.1
—
—
—
0
0
(3034426) Prothrombin time (PT)
5
14
3.60
1.62
1.6
1.4
—
—
—
0
0
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
14
70
2.03
1.60
1.6
1.9
—
—
—
0
0
(3035880) pH of Pleural fluid
8
32
2.52
1.60
1.6
1.3
—
—
—
0
0
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
10
44
2.30
1.54
2.0
2.4
—
—
—
0
0
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
22
131
1.71
1.52
1.2
1.3
—
—
—
0
0
(3024263) Appearance of Synovial fluid
7
27
2.61
1.52
1.4
1.5
—
—
—
0
0
(3045788) Cell count panel - Pleural fluid
11
51
2.18
1.51
2.8
1.3
—
—
—
0
0
(44790049)
12
58
2.10
1.50
1.4
1.7
—
—
—
0
0
(44806118)
12
58
2.10
1.50
1.4
1.7
—
—
—
0
0
(3012441) Differential panel - Pleural fluid
12
58
2.10
1.50
2.5
1.4
—
—
—
0
0
(44790047)
12
58
2.10
1.50
1.4
1.7
—
—
—
0
0
(44790048)
12
58
2.10
1.50
1.4
1.7
—
—
—
0
0
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
14
72
1.97
1.50
1.0
1.0
—
—
—
0
0
(3007164) IgA [Mass/volume] in Serum or Plasma
91
728
1.31
1.46
1.5
1.4
g/l
2.9
2.9
0.07
54
441
(3000475) Leukocytes [#/volume] in Synovial fluid
21
125
1.71
1.46
1.1
1.7
e6/l
4604.9
15600.5
1.66
14
97
(3016650) Hepatitis A virus Ab [Presence] in Serum
14
74
1.92
1.40
1.0
1.1
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
135
1578
0.80
1.39
3.9
3.9
—
—
—
0
0
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
76
951
0.76
1.37
1.6
1.8
pmol/l
475.2
19872216.8
0.69
66
780
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
9
42
2.16
1.34
1.0
1.0
—
—
—
0
0
(3044927) Protein electrophoresis panel - Urine
12
61
1.99
1.34
1.1
1.2
—
—
—
0
0
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
0
41
0.00
1.31
0.0
1.1
—
—
—
0
0
(3035637) Corticotropin [Mass/volume] in Plasma
9
43
2.11
1.31
1.6
1.8
—
—
—
0
0
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
8
34
2.37
1.29
1.1
1.4
—
—
—
0
0
(3000494) Fungus identified in Specimen by Culture
70
553
1.31
1.24
1.6
1.5
—
—
—
0
0
(40768806) Pleura Pathology biopsy report
12
63
1.93
1.23
1.8
1.6
—
—
—
0
0
(4281824)
8
38
2.12
1.19
1.6
1.3
—
—
—
0
0
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
17
102
1.69
1.17
1.5
1.3
—
—
—
0
0
(3001019) Free T4 and TSH panel - Serum or Plasma
18
110
1.66
1.17
1.8
1.5
—
—
—
0
0
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
8
39
2.07
1.15
1.0
1.2
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
23
341
0.66
1.15
4.6
3.8
—
—
—
0
0
(3017181) Myelocytes/100 leukocytes in Blood
27
386
0.68
1.13
2.7
4.5
%
0.4
0.8
—
9
134
(3025159) Blasts/100 leukocytes in Blood
23
339
0.66
1.12
2.6
4.6
%
1.6
0.1
—
7
108
(3021788) Differential panel - Synovial fluid
15
88
1.73
1.12
1.1
1.6
—
—
—
0
0
(3021440) Promyelocytes/100 leukocytes in Blood
25
361
0.68
1.11
2.6
4.6
%
0.1
0.1
—
9
123
(3033799) Differential panel - Peritoneal fluid
5
21
2.39
1.09
3.4
2.0
—
—
—
0
0
(3000919) Neutrophils/100 leukocytes in Pleural fluid
5
21
2.39
1.09
1.6
1.1
%
28.8
35.8
—
5
16
(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma
8
41
1.97
1.09
1.0
1.0
mg/l
320.1
292.7
—
8
36
(36660697) Celiac disease serology panel - Serum
36
262
1.40
1.09
1.1
1.2
—
—
—
0
0
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
15
89
1.71
1.08
1.5
2.0
—
—
—
0
0
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
44
333
1.35
1.06
4.0
4.0
ng/l
139.7
92.8
1.48
37
290
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
9
46
1.97
1.04
1.2
1.4
—
—
—
0
0
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
10
53
1.90
1.02
1.6
2.0
—
—
—
0
0
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
12
68
1.78
1.01
1.3
1.4
—
—
—
0
0
(3002179) Metamyelocytes/100 leukocytes in Blood
24
342
0.69
1.01
2.2
4.4
%
0.2
0.4
—
6
99
(3030981) Hyaline casts [#/volume] in Urine by Automated count
18
272
0.65
1.01
3.2
3.0
e6/l
0.1
0.2
1.69
18
265
(40761535) Cells panel - Urine sediment
50
390
1.31
1.00
3.5
3.5
—
—
—
0
0
(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay
9
49
1.85
0.99
1.0
1.1
—
—
—
0
0
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
14
84
1.69
0.98
1.3
1.4
—
—
—
0
0
(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma
5
23
2.19
0.98
1.0
2.4
u/ml
2255.6
948.1
—
5
23
(3006184) Hemoglobin [Mass/volume] in Capillary blood
17
108
1.59
0.97
1.5
2.5
g/l
127.1
126.9
—
8
79
(3016750) Collection duration of Urine
0
32
0.00
0.95
0.0
2.8
—
502.6
—
0
22
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
25
175
1.45
0.95
1.2
1.2
iu/ml
16.7
131.8
—
5
59
(4034850)
21
142
1.50
0.94
18.2
12.5
—
—
—
0
0
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
6
27
2.24
0.93
1.5
1.2
—
—
—
0
0
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
161
1438
1.18
0.93
2.6
2.6
u/l
65.4
57.9
0.81
151
1345
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
9
52
1.74
0.93
3.0
2.9
—
—
—
0
0
(3019225) pH of Specimen
34
449
0.74
0.92
5.6
4.8
—
—
—
0
0
(4094501)
19
126
1.53
0.92
1.1
1.1
—
—
—
0
0
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
6
28
2.16
0.91
2.5
1.5
—
—
—
0
0
(3002256) Pathology report gross observation
69
570
1.24
0.89
1.2
1.3
—
—
—
0
0
(4268621)
8
44
1.83
0.86
3.4
2.3
—
—
—
0
0
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
291
2735
1.15
0.84
3.4
3.4
u/l
71.6
58.0
1.30
271
2549
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
25
180
1.41
0.83
1.2
1.5
—
—
—
0
0
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
21
294
0.70
0.82
2.1
1.8
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
19
271
0.69
0.82
1.3
1.4
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
29
216
1.36
0.80
1.2
1.3
—
—
—
0
0
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
0
24
0.00
0.79
0.0
1.2
—
—
—
0
0
(3014051) Protein [Presence] in Urine by Test strip
15
98
1.55
0.79
1.7
2.1
—
—
—
0
0
(3042111) Morphology [Interpretation] in Bone marrow Narrative
14
90
1.57
0.79
1.3
2.0
—
—
—
0
0
(3000012) Reticulocyte production index
0
27
0.00
0.77
0.0
2.0
—
—
—
0
0
(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum
0
27
0.00
0.77
0.0
1.2
—
0.4
—
0
16
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
0
27
0.00
0.77
0.0
1.3
—
173.2
—
0
6
(3017446) Testosterone [Moles/volume] in Serum or Plasma
38
479
0.78
0.76
1.9
2.3
nmol/l
11.6
13.1
0.79
33
423
(3035350) Ketones [Presence] in Urine by Test strip
218
2018
1.14
0.76
3.4
3.7
estimate
0.0
0.0
0.00
25
388
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
13
83
1.58
0.75
1.1
1.1
—
—
—
0
0
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
7
38
1.85
0.74
1.7
1.9
—
—
—
0
0
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
25
185
1.37
0.73
1.6
3.0
—
—
—
0
0
(3007930) Methemoglobin/Hemoglobin.total in Blood
29
220
1.34
0.73
17.0
5.5
%
1.0
0.9
1.25
24
210
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
48
584
0.80
0.73
4.9
4.8
%
34.6
31.5
1.39
38
395
(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood
29
221
1.33
0.71
17.0
5.4
%
1.9
1.6
0.88
24
211
(3019832) Treponema pallidum Ab [Presence] in Serum
20
147
1.38
0.62
1.0
1.5
—
—
—
0
0
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
10
63
1.60
0.62
1.3
1.6
—
—
—
0
0
(3028707) Methadone [Presence] in Urine by Screen method
5
30
1.67
0.61
3.0
1.3
—
—
—
0
0
(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay
8
50
1.61
0.61
1.1
1.2
%
83.8
112.0
—
8
45
(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood
0
20
0.00
0.60
0.0
3.3
—
—
—
0
0
(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood
0
20
0.00
0.60
0.0
3.3
—
—
—
0
0
(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma
0
21
0.00
0.60
0.0
1.4
—
0.1
—
0
13
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
56
476
1.20
0.59
4.4
3.6
—
—
—
0
0
(3037556) Urate [Mass/volume] in Serum or Plasma
0
23
0.00
0.58
0.0
1.4
—
—
—
0
0
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
30
238
1.28
0.58
2.3
2.4
—
—
—
0
0
(3009261) Glucose [Presence] in Urine by Test strip
218
2048
1.11
0.56
3.5
3.7
estimate
0.0
0.0
0.00
26
377
(4306422)
8
55
1.46
0.56
1.1
1.3
—
—
—
0
0
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
8
55
1.46
0.56
2.0
3.6
—
—
—
0
0
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
8
55
1.46
0.56
1.1
1.1
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
10
65
1.55
0.56
1.4
1.6
—
—
—
0
0
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
10
65
1.55
0.56
1.4
1.6
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
10
65
1.55
0.56
1.4
1.6
—
—
—
0
0
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
6
38
1.59
0.54
1.0
1.1
—
—
—
0
0
(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum
18
134
1.36
0.53
1.0
1.1
—
—
—
0
0
(44816559) Phosphatidylethanol [Mass/volume] in Blood
13
91
1.44
0.53
1.2
1.3
—
—
—
0
0
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
6
39
1.54
0.53
1.2
1.9
—
—
—
0
0
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
14
192
0.72
0.53
1.5
1.4
—
—
—
0
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
10
66
1.53
0.53
1.4
1.6
—
—
—
0
0
(1761482) Bacteria [#/volume] in Urine by Culture
9
135
0.66
0.52
5.6
5.2
—
—
—
0
0
(3045414) Leukocytes [Presence] in Urine
24
188
1.29
0.52
1.6
1.8
—
—
—
0
0
(3021601) Nitrite [Presence] in Urine by Test strip
214
2016
1.11
0.52
4.9
5.0
estimate
0.0
0.0
0.00
27
394
(3029937) Albumin [Presence] in Urine by Test strip
101
1115
0.88
0.51
3.7
3.9
estimate
0.0
0.0
0.50
25
370
(3024522) Salmonella sp identified in Specimen by Organism specific culture
9
65
1.39
0.51
1.4
1.6
—
—
—
0
0
(40768800) Prostate Pathology biopsy report
12
167
0.71
0.50
1.1
1.2
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
21
163
1.30
0.49
1.2
1.4
—
—
—
0
0
(4062490)
7
45
1.56
0.49
1.1
1.2
—
—
—
0
0
(40768795) Lymph node Pathology biopsy report
7
45
1.56
0.49
1.3
1.2
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
7
46
1.53
0.48
1.3
1.9
—
—
—
0
0
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
22
173
1.28
0.47
1.5
1.8
—
—
—
0
0
(3038177) Helicobacter pylori Ab [Presence] in Serum
7
49
1.43
0.46
1.1
1.3
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
20
253
0.78
0.45
1.3
1.4
—
—
—
0
0
(3048689) Calprotectin [Mass/mass] in Stool
36
426
0.83
0.45
2.6
2.3
ug/g
153.7
138.3
0.14
28
343
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
7
50
1.41
0.45
1.3
1.8
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
7
50
1.41
0.45
1.3
1.8
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
7
50
1.41
0.45
1.3
1.8
—
—
—
0
0
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
7
51
1.38
0.44
1.0
1.1
—
—
—
0
0
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
160
1498
1.10
0.43
2.7
3.1
ug/l
0.7
0.8
0.36
98
1015
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
5
31
1.62
0.43
1.0
1.2
—
—
—
0
0
(3017704) Immunofixation for Urine
5
32
1.57
0.42
1.2
1.8
—
—
—
0
0
(3014148) Varicella zoster virus Ab [Titer] in Serum
5
33
1.52
0.41
1.2
1.1
—
—
—
0
0
(3000081) cloZAPine [Moles/volume] in Serum or Plasma
0
15
0.00
0.41
0.0
17.3
—
1502.1
—
0
15
(4015189)
0
15
0.00
0.41
0.0
2.3
—
—
—
0
0
(3029075) Extractable nuclear Ab panel - Serum
0
15
0.00
0.41
0.0
1.0
—
—
—
0
0
(3020650) Glucose [Presence] in Urine
0
15
0.00
0.41
0.0
1.2
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
29
241
1.22
0.41
1.2
1.3
—
—
—
0
0
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
8
59
1.36
0.41
1.8
2.0
—
—
—
0
0
(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood
0
17
0.00
0.40
0.0
1.9
—
—
—
0
0
(1002224) Polysomnography panel
19
150
1.28
0.40
1.2
1.1
—
—
—
0
0
(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH
0
18
0.00
0.40
0.0
1.1
—
—
—
0
0
(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection
0
18
0.00
0.40
0.0
1.3
—
—
—
0
0
(3048929) Epstein Barr virus Ab [Presence] in Serum
14
106
1.33
0.39
1.1
1.2
—
—
—
0
0
(3039443) Prostate specific Ag panel - Serum or Plasma
12
159
0.75
0.39
1.5
1.7
—
—
—
0
0
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
23
188
1.23
0.38
1.7
2.0
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
17
134
1.28
0.37
1.9
1.6
—
—
—
0
0
(3009508) Creatinine [Moles/volume] in Urine
155
1460
1.09
0.37
2.8
3.2
mmol/l
7.2
8.1
1.73
132
1207
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
216
2064
1.08
0.36
4.1
4.4
%
24.7
21.0
1.65
94
1004
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
12
90
1.34
0.36
1.2
1.7
—
—
—
0
0
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
9
123
0.73
0.35
1.8
2.2
—
—
—
0
0
(40768797) Stomach Pathology biopsy report
64
581
1.12
0.32
1.3
1.3
—
—
—
0
0
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
11
83
1.33
0.32
1.1
1.6
—
—
—
0
0
(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood
16
129
1.25
0.30
1.4
1.5
iu/ml
0.0
0.0
—
5
27
(40768804) Tissue Pathology biopsy report
156
1640
0.93
0.30
2.0
2.2
—
—
—
0
0
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
7
56
1.25
0.29
1.9
2.0
—
—
—
0
0
(3013512) EKG study
149
1417
1.07
0.28
7.3
4.2
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
8
63
1.27
0.28
2.9
1.3
—
—
—
0
0
(3045142) Bone marrow Pathology biopsy report
8
63
1.27
0.28
1.0
1.3
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
8
66
1.22
0.27
3.0
1.3
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
8
67
1.20
0.26
3.1
1.3
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
8
67
1.20
0.26
2.9
1.3
—
—
—
0
0
(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma
5
72
0.69
0.26
1.0
1.1
g/l
1.7
1.6
—
5
64
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
9
73
1.24
0.25
1.1
1.8
—
—
—
0
0
(3023419) Bacteria identified in Sputum by Culture
9
74
1.22
0.25
1.8
2.5
—
—
—
0
0
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
27
308
0.87
0.25
2.0
3.9
mmol/l
1.4
1.8
0.19
21
238
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
48
437
1.11
0.24
1.5
1.5
—
—
—
0
0
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
83
777
1.08
0.24
1.2
1.2
u/ml
0.8
1.4
1.38
12
215
(3012516) Albumin [Mass/volume] in Urine
149
1427
1.06
0.23
2.8
3.3
mg/l
881.7
190.6
0.63
101
971
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
40
441
0.90
0.23
1.4
1.3
—
—
—
0
0
(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
(3000285) Sodium [Moles/volume] in Blood
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(3021162) Amylase [Enzymatic activity/volume] in Specimen
0
10
0.00
0.21
0.0
3.7
—
7727.7
—
0
10
(3002067) Lambda light chains [Mass/time] in 24 hour Urine
0
10
0.00
0.21
0.0
3.5
—
—
—
0
0
(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum
0
10
0.00
0.21
0.0
1.5
—
—
—
0
0
(3019473) Protein [Mass/volume] in Cerebral spinal fluid
8
104
0.77
0.21
1.0
1.2
mg/l
498.5
528.1
—
8
99
(3016628) Fibrinogen Ag [Mass/volume] in Platelet poor plasma by Immunoassay
0
12
0.00
0.21
0.0
1.3
—
0.7
—
0
7
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
49
531
0.91
0.21
3.5
4.7
ug/l
5.7
37.0
1.31
37
453
(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection
0
13
0.00
0.21
0.0
1.1
—
—
—
0
0
(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection
0
13
0.00
0.21
0.0
1.1
—
—
—
0
0
(3035933) Granulocytes/100 leukocytes in Blood
0
13
0.00
0.21
0.0
1.1
—
—
—
0
0
(40768443) Skin Pathology biopsy report
21
183
1.15
0.20
1.1
1.2
—
—
—
0
0
(3022621) pH of Urine by Test strip
25
281
0.88
0.20
2.5
2.7
—
—
—
0
0
(1001926) Buprenorphine [Presence] in Urine by Screen method
6
50
1.20
0.19
3.5
1.2
—
—
—
0
0
(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma
12
99
1.22
0.19
1.3
1.1
u/l
26.3
37.9
0.41
12
86
(3003740) Influenza virus B Ag [Presence] in Specimen
6
51
1.18
0.19
1.0
1.1
—
—
—
0
0
(3002523) Influenza virus A Ag [Presence] in Specimen
6
52
1.16
0.19
1.0
1.1
—
—
—
0
0
(3029080) Hemoglobin [Entitic mass] in Reticulocytes
5
70
0.71
0.17
2.4
2.3
pg
34.8
33.2
—
5
70
(3033705) Calcium.ionized [Moles/volume] in Venous blood
8
69
1.16
0.16
3.9
3.1
—
—
—
0
0
(3035285) Chloride [Moles/volume] in Venous blood
8
71
1.13
0.16
3.9
3.1
mmol/l
107.4
105.2
—
8
71
(3041354) Potassium [Moles/volume] in Venous blood
8
71
1.13
0.16
3.9
3.1
mmol/l
4.2
4.1
—
8
71
(3030905) Polymorphonuclear cells [#/volume] in Blood
6
77
0.78
0.15
3.0
2.7
e9/l
3.9
4.7
—
6
77
(3044290) Cell count panel - Cerebral spinal fluid
6
78
0.77
0.15
1.0
1.2
—
—
—
0
0
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
6
78
0.77
0.15
2.5
3.4
—
—
—
0
0
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
6
80
0.75
0.15
3.0
3.1
%
60.8
57.5
—
6
80
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
9
81
1.11
0.15
1.1
1.7
—
—
—
0
0
(3022313) Gas panel - Capillary blood
22
244
0.90
0.15
2.0
3.9
—
—
—
0
0
(3022145) Colonoscopy Study observation
48
511
0.93
0.14
1.3
1.3
—
—
—
0
0
(3020682) Albumin/Creatinine [Ratio] in Urine
156
1516
1.04
0.14
3.3
4.0
mg/mmol
15.5
9.6
0.63
102
1001
(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay
8
98
0.81
0.14
1.0
1.1
—
11.7
—
0
9
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
22
200
1.10
0.12
1.2
1.3
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
86
888
0.96
0.10
3.3
4.9
—
—
—
0
0
(3037121) Protein [Mass/volume] in Urine
19
174
1.10
0.09
1.6
3.5
g/l
0.3
0.2
0.30
11
78
(3049717) Cytology report of Urine Cyto stain
27
252
1.08
0.09
4.0
2.9
—
—
—
0
0
(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid
5
48
1.04
0.09
1.0
1.1
—
—
—
0
0
(40768793) Breast Pathology biopsy report
5
60
0.83
0.08
1.0
1.3
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
7
64
1.10
0.08
3.1
1.3
—
—
—
0
0
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
7
68
1.03
0.08
1.1
1.0
—
—
—
0
0
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
8
77
1.04
0.07
1.0
1.1
—
—
—
0
0
(3042631) Mycobacterium sp identified in Specimen
8
78
1.03
0.07
2.5
2.8
—
—
—
0
0
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
9
85
1.06
0.07
1.4
1.3
—
—
—
0
0
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
9
86
1.05
0.07
1.2
1.7
—
—
—
0
0
(3021901) Oxygen saturation in Capillary blood
8
90
0.89
0.07
2.4
3.1
—
—
—
0
0
(3012501) Base excess in Blood by calculation
11
99
1.11
0.06
3.3
5.1
mmol/l
1.7
2.2
—
5
64
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
16
172
0.93
0.06
1.0
1.0
—
—
—
0
0
(3036481) Cortisol [Moles/volume] in Serum or Plasma
38
395
0.96
0.06
3.0
2.2
nmol/l
402.6
370.0
0.64
33
365
(3000330) Specific gravity of Urine by Test strip
25
237
1.06
0.06
3.2
4.1
—
—
—
0
0
(4010399)
31
324
0.95
0.05
1.2
1.4
—
—
—
0
0
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
252
2542
0.98
0.05
4.5
5.1
ug/l
1.9
2.8
1.44
225
2289
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
121
1192
1.02
0.05
1.5
1.7
mmol/l
1.3
1.4
0.57
109
994
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
62
633
0.98
0.03
1.3
1.2
iu/ml
24.8
37.5
0.98
27
195
(3019150) Specific gravity of Urine by Refractometry
91
896
1.02
0.03
4.0
4.0
kg/l
1.0
1.0
0.34
11
130
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
59
602
0.98
0.03
1.2
1.3
u/ml
15.0
10.0
0.16
18
230
(40767503) Oxygen content in Capillary blood by calculation
11
102
1.08
0.03
2.5
2.9
%
16.2
15.7
—
6
52
(4035726)
43
421
1.02
0.02
1.7
1.4
—
—
—
0
0
(3017732) Neutrophils [#/volume] in Blood
28
272
1.03
0.02
2.0
2.7
e9/l
3.9
4.0
0.05
22
200
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
11
116
0.95
0.00
1.5
1.5
—
—
—
0
0
(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum
24
243
0.99
0.00
1.3
1.4
—
46.1
—
0
14
(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum
28
278
1.01
0.00
2.4
2.5
—
13.5
—
0
11
(3008898) HLA-B27 [Presence]
10
101
0.99
0.00
1.0
1.1
—
—
—
0
0
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
50
502
1.00
0.00
1.8
1.9
%
1.7
1.6
0.41
40
414
(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay
5
49
1.02
0.00
1.2
1.0
—
2.3
—
0
16
(21494434) Karyotype in Bone marrow
5
59
0.85
0.00
1.0
1.3
—
—
—
0
0
(21494890) Protein electrophoresis panel - 24 hour Urine
6
59
1.02
0.00
1.3
2.5
—
—
—
0
0
(3017817) Protein [Mass] in Urine collected for unspecified duration
5
49
1.02
0.00
1.8
2.6
—
—
—
0
0
(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma
0
8
0.00
0.00
0.0
1.6
—
—
—
0
0
(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(1616796) Gas panel - Central venous blood
9
95
0.95
0.00
2.8
4.3
—
—
—
0
0
(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection
0
9
0.00
0.00
0.0
2.6
—
—
—
0
0
(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture
0
7
0.00
0.00
0.0
3.0
—
—
—
0
0
(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3051101) Glucose [Moles/volume] in Cord blood
0
8
0.00
0.00
0.0
5.0
—
—
—
0
0
(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(40758355) Pancreatic polypeptide [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
2.6
—
109.2
—
0
5
(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3035457) Cefaclor IgE Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3013762) Body weight Measured
0
5
0.00
0.00
0.0
1.8
—
—
—
0
0
(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3004269) Kappa light chains [Mass/time] in 24 hour Urine
0
8
0.00
0.00
0.0
4.0
—
—
—
0
0
(3026726) Creatinine [Moles/volume] in Specimen
0
8
0.00
0.00
0.0
2.6
—
142.6
—
0
8
(3010254) Herpes simplex virus identified in Specimen by Organism specific culture
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3018851) Theophylline [Moles/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
1.4
—
39.1
—
0
7
(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture
0
7
0.00
0.00
0.0
3.0
—
—
—
0
0
(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma
0
9
0.00
0.00
0.0
2.2
—
15.7
—
0
9
(3045424) Erythrocytes [Presence] in Urine
7
74
0.95
0.00
1.6
1.4
—
—
—
0
0
(40762814) Titanium [Mass/volume] in Blood
0
6
0.00
0.00
0.0
2.5
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
9
91
0.99
0.00
1.1
1.1
—
—
—
0
0
(3027300) Silver Birch IgE Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3050794) Legionella sp Ab [Presence] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3012320) Pathologist interpretation of Cerebral spinal fluid tests
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.5
—
73.7
—
0
6
(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(3030366) Cystatin C [Mass/volume] in Serum or Plasma
13
130
1.00
0.00
2.6
3.0
mg/l
2.1
1.7
0.64
13
117
(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid
0
7
0.00
0.00
0.0
1.4
—
—
—
0
0
(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.2
—
12.8
—
0
5
(3030313) Adrenal Ab [Titer] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
7
71
0.99
0.00
1.1
1.8
—
—
—
0
0
(4146454)
6
62
0.97
0.00
3.8
2.7
—
—
—
0
0
(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3038769) Chlamydophila pneumoniae IgG Ab [Units/volume] in Serum by Immunoassay
0
5
0.00
0.00
0.0
1.0
—
27.2
—
0
5
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
7
74
0.95
0.00
1.1
1.2
—
—
—
0
0
(3013293) Extractable nuclear Ab [Presence] in Serum
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
(40760435) Tropomyosin IgE Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0

Mortality – FinRegistry

↥

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

Relationships between endpoints

↥

Index endpoint: AF_OPER – Operations for atrial fibrillation

GWS hits: -

This endpoint is excluded from FinRegistry analyses (omitted endpoint).